Table 1 Demographic of Patients with RA
99Tc 99Tc & GC
Number 27 42
Sex (Female) 21 30
Age (Mean ± SD) 54 ± 9.22 52 ± 7.62
BMI 21.78 ± 2.41 21.64 ± 2.57
Hypertension 4 6
Alcohol 2 1
Smoking 4 7
Female Menopause (N, %) 13 (61.9%) 21 (70%)
Age of Menopause 50.2 ± 2.44 47.6 ± 3.41
Duration of Disease (Y) 0.25 - 10 0.42 - 28
Drugs* 99Tc + DMARDs 99Tc+ GC +DMARDs
Anti-CCP* 170.9 ± 186.80 405.7 ± 657.34
RF* 121.3 ± 65.59 82.3 ± 68.57
DMARDs include Methotrexate, Leflunomide, and Sulfasalazine, Hydroxy chloroquine, Thalidomide, and Iguratimod, which have been regular used for the patients with RA through administration of single or combination. Anti-CCP is antibodies to cyclocitrullinate peptide. RF is rheumatoid factor. 99Tc is 99Tc-MDP and GC is glucocorticoid. 99Tc is 99Tc-MDP and GC is Glucocorticoid. *DMARDs include Methotrexate, Leflunomide, and Sulfasalazine, Hydroxy chloroquine, Thalidomide, and Iguratimod, which have been regular used for the patients with RA through administration of single or combination. Anti-CCP is antibodies to cyclocitrullinate peptide. RF is rheumatoid factor. 99Tc is 99Tc-MDP and GC is glucocorticoid. 99Tc is 99Tc-MDP and GC is Glucocorticoid. *DMARDs include Methotrexate, Leflunomide, and Sulfasalazine, Hydroxy chloroquine, Thalidomide, and Iguratimod, which have been regular used for the patients with RA through administration of single or combination. Anti-CCP is antibodies to cyclocitrullinate peptide. RF is rheumatoid factor. 99Tc is 99Tc-MDP and GC is glucocorticoid. 99Tc is 99Tc-MDP and GC is Glucocorticoid.